Start main content

Mobile SARS-Cov-2 Detection/COVID-19 Diagnostic Assay

Mobile SARS-Cov-2 Detection/COVID-19 Diagnostic Assay
Field
Molecular Diagnostics
Patent
IP00946

Key Problem and Market Opportunity

  • To control the COVID-19 pandemic and prevent its resurgence in areas preparing for a return of economic activities, a method for a rapid, simple, and inexpensive diagnosis and mass screening is urgently needed
  • Currently, the gold standard for SARS-CoV-2 detection is based on qRT-PCR
  • SARS-CoV-2 detection by qRT-PCR requires expensive qPCR machines and regents. Thus the cost is high, and the assay is not deploy-able on mobile units
  • Hence, a low cost, simple and mobile COVID-19 diagnostic assay is needed

Key advantages of the technology

Technology Section Slider 1
Technology Section Slider 2
  • A one-step colorimetric reverse-transcriptional loop-mediated isothermal amplification assay (COVID-19-LAMP) for detection of SARS-CoV-2
  • The sensitivity and specificity of are 98.21% and 100% respectively
  • The assay involves simple equipment and techniques and is low cost, without the need for expensive qPCR machines. The result, indicated by color change, is easily interpreted by naked eyes
  • can detect SARS-CoV-2 RNA with a detection limit of 42 copies/reaction
  • can be useful for rapid deployment as mobile diagnostic units to resource-limiting areas for point-of-care diagnosis, and for unlimited high-throughput mass screening at borders to reduce cross-regional transmission

Potential Product and Services

  • COVID-19-LAMP Rapid Diagnostic Kit
  • Simple, rapid, low cost COVID-19 diagnostic services in medical laboratories, mobile diagnostic units for border control, lockdown areas, remote areas, developing countries etc

Development stage and IP strength

  • US Provisional Patent application: 63/024,887
  • Journal publication: https://www.mdpi.com/1422-0067/21/15/5380
  • To control the COVID-19 pandemic and prevent its resurgence in areas preparing for a return of economic activities, a method for a rapid, simple, and inexpensive diagnosis and mass screening is urgently needed
  • Verified with more than 380 clinical samples.

Work with us